N@N

PCLN, VRTX, GPRO, HSC, PSA, FNF Expected to Trade Up Short Term

June 17, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top equities trading strategies and these stocks are the most likely to trade Up in the coming weeks. PRICELINE.COM INC (NASDAQ:PCLN), VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX), GEN-PROBE INC (NASDAQ:GPRO), HARSCO CORP (NYSE:HSC), PUBLIC STORAGE (NYSE:PSA), FIDELITY NATIONAL FINL-A (NYSE:FNF) are all expected to go Up as Bullish signals have been generated by top equity trading strategies. This trading system is designed to identify high probability reversion to mean trading candidates. It looks to go long immediately following strong sell-offs, and goes short after sharp run ups. Its trades are short term and hone in on the irrational decisions of emotional traders around these extreme moves. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php The chart below displays the stocks expected to go Up and a suggested stop level to limit any potential trading losses.

     Symbol     Company                             Price          Price Stop Level
     PCLN       PRICELINE.COM INC                   461.710        438.87    
     VRTX       VERTEX PHARMACEUTICALS INC          45.590         40.61     
     GPRO       GEN-PROBE INC                       67.010         63.18     
     HSC        HARSCO CORP                         29.900         28.07     
     PSA        PUBLIC STORAGE                      110.700        106.14    
     FNF        FIDELITY NATIONAL FINL-A            15.060         14.38     

PRICELINE.COM INC (NASDAQ:PCLN) - priceline.com Incorporated operates as an online travel company principally in the United States, Europe, and Asia. It provides various travel services, including airline tickets, hotel rooms, car rentals, vacation packages, cruises, and reservation services. The company also provides destination services, such as parking, event tickets, ground transfers, tours, and other services available at their travel destinations; and travel insurance package that provides coverage for trip cancellation, trip interruption, medical expenses, and emergency evacuation, as well as for the loss of baggage, property, and travel documents. In the United States, it offers its customers a choice that gives the ability to purchase travel services in a traditional, price-disclosed manner or the opportunity to use its Name Your Own Price service, which allows the customers to make offers for travel services at discounted prices. The company offers its products and services under priceline.com, Booking.com, Active Hotels, Agoda, Lowestfare.com, Rentalcars.com, Breezenet.com, MyTravelGuide.com, and Travelweb brands. priceline.com Incorporated was founded in 1997 and is headquartered in Norwalk, Connecticut.

VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) - Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide. Its product pipeline includes Telaprevir (VX-950), a Phase III clinical trial product for the treatment of hepatitis C virus (HCV) infection; VX-222, a Phase IIa clinical trial product targeting HCV infection; VX-770, a Phase III clinical trial candidate for the treatment of cystic fibrosis; and VX-809, a Phase IIa clinical trial product targeting cystic fibrosis. The companys products also comprise VX-509, a Phase IIa clinical trial product for the treatment of rheumatoid arthritis; VX-765, a Phase IIa clinical trial product targeting epilepsy; and VX-759, a Phase I clinical trial product for the treatment of HCV infection. It has collaboration agreements with Janssen Pharmaceutica, N.V.; Mitsubishi Tanabe Pharma Corporation; Cystic Fibrosis Foundation Therapeutics Incorporated; Merck & Co., Inc.; and GlaxoSmithKline plc. The company was founded in 1989 and is headquartered in Cambridge, Massachusetts.

GEN-PROBE INC (NASDAQ:GPRO) - Gen-Probe Incorporated engages in the development, manufacture, and marketing of nucleic acid tests used primarily to diagnose human diseases and screen donated human blood in North America and internationally. The company markets a portfolio of products to detect infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, and other infections. Its primarily product line includes APTIMA Combo 2 assay, APTIMA CT, APTIMA GC assays, and PACE family of assays to detect chlamydia and gonorrhea; APTIMA Trichomonas ASRs to detect trichomonas; APTIMA HPV assay to detect 14 sub-types of high-risk HPV associated with cervical cancer; and AccuProbe Group B Streptococcus (GBS) assay to detect GBS from culture. The companys product line also include APTIMA HIV-1 assay to detect RNA from HIV-1, the virus that causes AIDS; APTIMA HCV assay to detect RNA from the hepatitis C virus; and ASRs for quantitative HCV testing to quantify HCV viral load. It also offers Pro-Flu+, Pro-Flu ST, ProGastro Cd, AMPLIFIED MTD, and GAS Direct for various respiratory infectious diseases; LIFECODES HLA DNA typing kits and LIFECODES LifeScreen antibody screening kits in the transplant diagnostics field; Procleix HIV-1/HCV assay, Procleix Ultrio assay, Procleix Ultrio Plus assay, and Procleix WNV assay for the blood donor screening market; and TIGRIS and Direct Tube Sampling instrument systems to develop instrumentation. In addition, the companys developing products include PANTHER, an automated testing instrument. Further, the company offers PROGENSA PCA3 and PCA3 ASRs to detect the PCA3 gene. The companys customers include reference laboratories, public health institutions, and hospitals. It has a collaboration agreement with Novartis Vaccines and Diagnostics, Inc. for the research, development, and manufacturing of its blood screening products. The company was founded in 1983 and is headquartered in San Diego, California.

HARSCO CORP (NYSE:HSC) - Harsco Corporation provides industrial services and engineered products worldwide. The company operates in four segments: Harsco Infrastructure, Harsco Metals & Minerals, Harsco Rail, and Harsco Industrial. The Harsco Infrastructure segment engages in the rental and sale of scaffolding, shoring, and concrete forming systems for industrial maintenance and capital improvement projects, civil infrastructure projects, non-residential construction, and international multi-dwelling residential construction projects, as well as offers various services, including project engineering and equipment installation. This segment provides its services to industrial and petrochemical plants; the infrastructure construction, repair, and maintenance markets; commercial and industrial construction contractors; and public utilities. The Harsco Metals & Minerals segment offers on-site and outsourced services, such as slag processing, semi-finished inventory management, material handling, scrap management, and in-plant transportation to steel mills and other metal producers comprising aluminum and copper. This segment also provides minerals and recycling technologies; environmental solutions for metals and mining customers waste streams; and granules for asphalt roofing shingles, as well as abrasives for industrial surface preparation derived from coal slag to steel mills and asphalt roofing manufacturers. The Harsco Rail segment manufactures railway track maintenance equipment; and offers track maintenance services to private and government-owned railroads, and urban mass transit systems. The Harsco Industrial segment provides industrial grating; air-cooled heat exchangers; and boilers and water heaters to industrial plants, non-residential, commercial and public construction, and retrofit markets, as well as to the natural gas exploration and processing industry. Harsco Corporation was founded in 1850 and is based in Camp Hill, Pennsylvania.

PUBLIC STORAGE (NYSE:PSA) - Public Storage operates as a real estate investment trust (REIT). It engages in the acquisition, development, ownership, and operation of self-storage facilities in the United States and Europe. The companys self-storage facilities offer storage spaces for lease on a month-to-month basis for personal and business use. Public Storage also has interests in commercial properties containing commercial and industrial rental space; facilities that lease storage containers; and ancillary operations, which include reinsurance of policies against losses to goods stored by its self-storage tenants, retail operations comprising merchandise sales and truck rental operations. As of December 31, 2008, the company had interests in 2,012 self-storage facilities with approximately 127 million net rentable square feet in 38 states; and 181 self-storage facilities with approximately 10 million net rentable square feet in 7 western European nations. It also had direct and indirect equity interests in approximately 21 million net rentable square feet of commercial space located in 11 states in the U.S. As a REIT, the company would not be subject to federal income tax to the extent that it distributes at least 90% of its taxable income to its shareholders. Public Storage was founded in 1971 and is based in Glendale, California.

FIDELITY NATIONAL FINL-A (NYSE:FNF) - Fidelity National Financial, Inc., through its subsidiaries, provides title insurance, specialty insurance, claims management services, and information services in the United States. The company primarily provides title insurance, escrow, and other title related services, including collection and trust activities, trustees sales guarantees, recordings, and reconveyances. It also offers specialty insurance products, such as flood, home warranty, homeowners, automobile, and personal lines insurance products. In addition, the company provides outsourced insurance claims management services to corporate and public sector entities, as well as offers information services in the human resources, retail, and transportation markets. It markets and distributes title and escrow products and services to national residential mortgage lenders, real estate investment trusts, and developers in the residential and commercial market sectors of the real estate industry. The company markets its specialty insurance products through an in-house agency, independent agents, and brokers. Fidelity National Financial, Inc. is headquartered in Jacksonville, Florida.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net